ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Price, Quote, News and Overview
NASDAQ:NNNN - Nasdaq - KYG0367B1059 - Common Stock - Currency: USD
NNNN Quote, Performance and Key Statistics
47.11
-3.72 (-7.32%)
The current stock price of NNNN is 47.11 USD. In the past month the price increased by 48.8%.
NNNN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.62 | 337.77B | ||
| AMGN | AMGEN INC | 14.62 | 163.23B | ||
| GILD | GILEAD SCIENCES INC | 14.76 | 142.09B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 120.29B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.6 | 60.26B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 43.10B | ||
| ARGX | ARGENX SE - ADR | 104.32 | 36.65B | ||
| ONC | BEONE MEDICINES LTD-ADR | 7.82 | 33.09B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.80B | ||
| INSM | INSMED INC | N/A | 19.92B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 19.86B | ||
| BIIB | BIOGEN INC | 8.08 | 18.74B |
Related stock screener links
About NNNN
Company Profile
Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products encompasses solutions for various applications, including over-the-counter (OTC) utilization, point-of-care (POCT) settings, and laboratory applications. The firm's product detects biomarkers associated with medical domains. These domains encompasses infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. In addition, the Company's IVD products are in line with multiple sample collection matrices, including serum, plasma, whole blood, feces, urine, and saliva, for both healthcare providers and patients. Its primary research and development activities for all IVD products includes Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer.
Company Info
ANBIO BIOTECHNOLOGY LTD
Friedrich-Ebert-Anlage 49
Frankfurt HESSEN DE
Employees: 27
Phone: 4916096247281
ANBIO BIOTECHNOLOGY LTD / NNNN FAQ
What is the stock price of ANBIO BIOTECHNOLOGY LTD today?
The current stock price of NNNN is 47.11 USD. The price decreased by -7.32% in the last trading session.
What is the ticker symbol for ANBIO BIOTECHNOLOGY LTD stock?
The exchange symbol of ANBIO BIOTECHNOLOGY LTD is NNNN and it is listed on the Nasdaq exchange.
On which exchange is NNNN stock listed?
NNNN stock is listed on the Nasdaq exchange.
What is ANBIO BIOTECHNOLOGY LTD worth?
ANBIO BIOTECHNOLOGY LTD (NNNN) has a market capitalization of 2.07B USD. This makes NNNN a Mid Cap stock.
How many employees does ANBIO BIOTECHNOLOGY LTD have?
ANBIO BIOTECHNOLOGY LTD (NNNN) currently has 27 employees.
What are the support and resistance levels for ANBIO BIOTECHNOLOGY LTD (NNNN) stock?
ANBIO BIOTECHNOLOGY LTD (NNNN) has a support level at 43.01 and a resistance level at 51.81. Check the full technical report for a detailed analysis of NNNN support and resistance levels.
Should I buy ANBIO BIOTECHNOLOGY LTD (NNNN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NNNN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NNNN, evaluating the profitability, health, valuation and growth aspects
- ANBIO BIOTECHNOLOGY LTD (NNNN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANBIO BIOTECHNOLOGY LTD (NNNN) Sales and EPS estimates to see what analysts future expectations are.
- ANBIO BIOTECHNOLOGY LTD (NNNN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANBIO BIOTECHNOLOGY LTD (NNNN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Chart to make your own analysis
- ANBIO BIOTECHNOLOGY LTD (NNNN) Latest news and press-releases to stay up to date.
Does ANBIO BIOTECHNOLOGY LTD (NNNN) stock pay dividends?
NNNN does not pay a dividend.
What is the Price/Earnings (PE) ratio of ANBIO BIOTECHNOLOGY LTD (NNNN)?
The PE ratio for ANBIO BIOTECHNOLOGY LTD (NNNN) is 1570.33. This is based on the reported non-GAAP earnings per share of 0.03 and the current share price of 47.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for NNNN.
What is the Short Interest ratio of ANBIO BIOTECHNOLOGY LTD (NNNN) stock?
The outstanding short interest for ANBIO BIOTECHNOLOGY LTD (NNNN) is 0.42% of its float. Check the ownership tab for more information on the NNNN short interest.
NNNN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NNNN.
NNNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NNNN. NNNN scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
NNNN Financial Highlights
Over the last trailing twelve months NNNN reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS increased by 5.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 38.63% | ||
| ROA | 19.95% | ||
| ROE | 21.95% | ||
| Debt/Equity | 0 |